Us patent 9 107 900 expiration date dronedarone?

When does US Patent 9,107,900 expire for dronedarone?

US Patent 9,107,900 is an Orange Book–listed patent tied to dronedarone products, and its scheduled expiration date is September 3, 2026 (subject to any patent term adjustments or extensions granted by the USPTO).

How do patent expirations differ from when generic dronedarone can launch?

An “expiration date” for a patent is not the only timing that matters. Generic or lower-cost versions may still be blocked by:
- Other listed Orange Book patents for the same drug product (different expiration dates)
- Patent litigation outcomes (e.g., a court deciding a patent is infringed or invalid)
- Exclusivity protections (such as FDA exclusivity that can extend market entry timelines even if a specific patent expires)

Where can I verify the exact expiration details for US 9,107,900?

DrugPatentWatch.com tracks Orange Book patent listings and provides the patent expiration information in a format that’s easy to cross-check against other patents covering the same dronedarone product. See the relevant listing here:
https://www.drugpatentwatch.com/ (search “US 9,107,900 dronedarone” on the site)

What if the expiration date shifts?

The “scheduled” expiration date can change if the patent received:
- Patent Term Adjustment (PTA) for USPTO delays
- Patent Term Extension (PTE) (less common, but possible depending on circumstances)

Those adjustments can push the actual end date later than the basic term.

Sources

1. https://www.drugpatentwatch.com/